Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 20 results.
User Information
Export Records
  1. 1.   Guide RNA biogenesis involves a novel RNase III family endoribonuclease in Trypanosoma brucei
  2. Madina, B. R.; Kuppan, G.; Vashisht, A. A.; Liang, Y. H.; Downey, K. M.; Wohlschlegel, J. A.; Ji, X. H.; Sze, S. H.; Sacchettini, J. C.; Read, L. K.; Cruz-Reyes, J.
  3. Rna-a Publication of the Rna Society. 2011, Oct; 17(10): 1821-1830.
  1. 2.   Electrostatic Interactions and Binding Orientation of HIV-1 Matrix Studied by Neutron Reflectivity
  2. Nanda, H.; Datta, S. A. K.; Heinrich, F.; Losche, M.; Rein, A.; Krueger, S.; Curtis, J. E.
  3. Biophysical Journal. 2010, Oct; 99(8): 2516-2524.
  1. 3.   The capsid-spacer peptide 1 Gag processing intermediate is a dominant-negative inhibitor of HIV-1 maturation
  2. Checkley, M. A.; Luttge, B. G.; Soheilian, F.; Nagashima, K.; Freed, E. O.
  3. Virology. 2010, Apr; 400(1): 137-144.
  1. 4.   Impact of Human Immunodeficiency Virus Type 1 Resistance to Protease Inhibitors on Evolution of Resistance to the Maturation Inhibitor Bevirimat (PA-457)
  2. Adamson, C. S.; Waki, K.; Ablan, S. D.; Salzwedel, K.; Freed, E. O.
  3. Journal of Virology. 2009 83(10): 4884-4894.
  1. 5.   Cellular proteins detected in HIV-1
  2. Ott, D. E.
  3. Reviews in Medical Virology. 2008 18(3): 159-175.
  1. 6.   Structural basis for viral late-domain binding to Alix
  2. Lee, S.; Joshi, A.; Nagashima, K.; Freed, E. O.; Hurley, J. H.
  3. Nature Structural & Molecular Biology. 2007, Mar; 14(3): 194-199.
  1. 7.   An Alix fragment potently inhibits HIV-1 budding - Characterization of binding to retroviral YPXL late domains
  2. Munshi, U. M.; Kim, J.; Nagashima, K.; Hurley, J. H.; Freed, E. O.
  3. Journal of Biological Chemistry. 2007, Feb; 282(6): 3847-3855.
  1. 8.   Determinants of activity of the HIV-1 maturation inhibitor PA-457
  2. Li, F.; Zoumplis, D.; Matallana, C.; Kilgore, N. R.; Reddick, M.; Yunus, A. S.; Adamson, C. S.; Salzwedel, K.; Martin, D. E.; Allaway, G. P.; Freed, E. O.; Wild, C. T.
  3. Virology. 2006, Dec; 356(1-2): 217-224.
  1. 9.   HIV-1 Gag: Flipped out for PI(4,5)P-2
  2. Freed, E. O.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2006, Jul; 103(30): 11101-11102.
  1. 10.   Nucleotide excision repair and template-independent addition by HIV-1 reverse transcriptase in the presence of nucleocapsid protein
  2. Bampi, C.; Bibillo, A.; Wendeler, M.; Divita, G.; Gorelick, R. J.; Le Grice, S. F. J.; Darlix, J. L.
  3. Journal of Biological Chemistry. 2006, Apr; 281(17): 11736-11743.
  1. 11.   A mutation in the human immunodeficiency virus type 1 gag protein destabilizes the interaction of the envelope protein subunits gp120 and gp41
  2. Davis, M. R.; Jiang, J. Y.; Zhou, J.; Freed, E. O.; Aiken, C.
  3. Journal of Virology. 2006, Mar; 80(5): 2405-2417.
  1. 12.   Proteins that bind high-mannose sugars of the HIV envelope
  2. Botos, I.; Wlodawer, A.
  3. Progress in Biophysics and Molecular Biology. 2005, JUN; 88(2): 233-282.
  1. 13.   A novel and efficient approach to discriminate between pre- and post-transcription HIV inhibitors
  2. Daelemans, D.; Pannecouque, C.; Pavlakis, G. N.; Tabarrini, O.; De Clercq, E.
  3. Molecular Pharmacology. 2005, MAY; 67(5): 1574-1580.
  1. 14.   Association of Ebola virus matrix protein VP40 with microtubules
  2. Ruthel, G.; Demmin, G. L.; Kallstrom, G.; Javid, M. P.; Badie, S. S.; Will, A. B.; Nelle, T.; Schokman, R.; Nguyen, T. L.; Carra, J. H.; Bavari, S.; Aman, M. J.
  3. Journal of Virology. 2005, APR; 79(8): 4709-4719.
  1. 15.   Weak palindromic consensus sequences are a common feature found at the integration target sites of many retroviruses
  2. Wu, X. L.; Li, Y.; Crise, B.; Burgess, S. M.; Munroe, D. J.
  3. Journal of Virology. 2005, APR; 79(8): 5211-5214.
  1. 16.   Human immunodeficiency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation
  2. Vazquez, N.; Greenwell-Wild, T.; Marinos, N. J.; Swaim, W. D.; Nares, S.; Ott, D. E.; Schubert, U.; Henklein, P.; Orenstein, J. M.; Sporn, M. B.; Wahl, S. M.
  3. Journal of Virology. 2005 79(7): 4479-4491.
  1. 17.   Role of murine leukemia virus nucleocapsid protein in virus assembly
  2. Muriaux, D.; Costes, S.; Nagashima, K.; Mirro, J.; Cho, E.; Lockett, S.; Rein, A.
  3. Journal of Virology. 2004, NOV; 78(22): 12378-12385.
  1. 18.   Integration target site selection for retroviruses and transposable elements
  2. Wu, X.; Burgess, S. M.
  3. Cellular and Molecular Life Sciences. 2004, OCT; 61(19-20): 2588-2596.
  1. 19.   Proteolytic events of HIV-1 replication as targets for therapeutic intervention
  2. Tozser, J.; Oroszlan, S.
  3. Current Pharmaceutical Design. 2003 9(22): 1803-1815.
  1. 20.   Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells
  2. Tang, S. X.; Murakami, T.; Agresta, B. E.; Campbell, S.; Freed, E. O.; Levin, J. G.
  3. Journal of Virology. 2001 75(19): 9357-9366.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel